Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT03977480 |
| Consolidated Lead Sponsor | Tianjin Hemay Pharmaceutical Co |
| Therapeutic Condition Cohort | Immunology, Rheumatology, and Dermatology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 70 participants (ACTUAL) |
| Registered Start Date | 2019-08-13 |
| WhyStopped Classification | Insufficient / Slow Accrual |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The First Affiliated Hospital of Anhui Medical University | Hefei, China | Open Hospital Dossier -> |
| Peking University People's Hospital | Beijing, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Xiamen University | Xiamen, China | Open Hospital Dossier -> |
| The first affiliated hospital of Guangxi Medical University | Nanning, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Immunology, Rheumatology, and Dermatology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.